Abnormally formed proteins may be involved in the pathology that causes schizophrenia in a subset of patients, new research suggests.
Johns Hopkins Medicine researchers say they’ve further characterized a set of chemical imbalances in the brains of people with schizophrenia.
In the largest study of its kind, involving more than 100,000 people, researchers at the Icahn School of Medicine at Mount Sinai have applied a novel machine learning method to identify 413 genetic associations with schizophrenia across 13 brain regions.
B-group vitamins may be beneficial for maintaining concentration skills among people experiencing a first episode of psychosis, a study by researchers from Orygen, the National Centre of Excellence in Youth Mental Health, has found.
Study reveals those with schizophrenia have an overall reduction of bodily sensations across all emotions, where as those without the disorder show specific patterns of increase arousal and decreased energy across the body for each emotion.